McNeill Jonathan
SEC insider (Form 3/4/5 filer). CIK 0001824673. President and COO at CRESCENT BIOPHARMA, INC. (CBIO). 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in WALTHAM, MA.
Companies McNeill Jonathan has filed insider reports for
- CRESCENT BIOPHARMA, INC. (CBIO): Officer, President and COO
McNeill Jonathan
CIK: 0001824673
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRESCENT BIOPHARMA, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 18, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect3.8K shares at avg. $16.71$64K - Sep 16, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect731 shares at avg. $17.90$13K - Jun 22, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect20.5K shares at avg. $17.99$370K - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect19.5K shares- - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect6K shares- - Dec 8, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirectStock Option (Right to Buy)
172.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 18, 2026 | CBIO CRESCENT BIOPHARMA, INC. | Sale | 3,839 | $16.71 | $64,150 | Direct |
| Sep 16, 2026 | CBIO CRESCENT BIOPHARMA, INC. | Sale | 731 | $17.90 | $13,085 | Direct |
| Jun 22, 2026 | CBIO CRESCENT BIOPHARMA, INC. | Sale | 20,549 | $17.99 | $369,677 | Direct |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | Award | 19,507 | - | - | Direct |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | Award | 6,000 | - | - | Direct |
| Dec 8, 2025 | CBIO CRESCENT BIOPHARMA, INC. | Award Stock Option (Right to Buy) | 172,836 | - | - | Direct |
1-6 of 6 transactions